Organization
Research and Development, NicOx SA, Sophia Antipolis, France
5 abstracts
Abstract
ASSESSMENT OF ANALGESIC TREATMENT SWITCH PATTERNS POST-ROFECOXIB WITHDRAWALOrg: Research and Development, NicOx SA, Sophia Antipolis, France, PHARMO Institute, Utrecht University, Netherlands Cancer Institute, Oncology Pain and Inflammation,
Abstract
AN IMMUNE TARGETED, NON-TOXIC CORTICOSTEROID FOR THE TREATMENT OF SEVERE AUTOIMMUNE DISEASEOrg: ImmuNext, Research and Development, NicOx SA, Sophia Antipolis, France,
Abstract
A RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, PLACEBO AND NAPROXEN CONTROLLED, MULTICENTER PHASE 3 STUDY OF NAPROXCINOD IN SUBJECTS WITH OSTEOARTHRITIS OF THE KNEE: EFFICACY RESULTS FOLLOWING 13-WEEK TREATMENT Org: Medicine, Deep South Clinical Research, Nederland, Medicine, Clinical Center of Asheville, Asheville, Medicine, Heartland Clinical Research, Omaha, Internal Medicine, R & R Research, Marion, Medicine, Clinical Investigation Specialist Inc, Gurnee,
Abstract
AUTOIMMUNE SCLERITIS RISK IN PERUVIAN ABORIGINES QUECHUAS WITH RHEUMATOID ARTHRITIS Org: Research and Development, NicOx SA, Sophia Antipolis, France, Rheumacenter, Juliaca, San Román, Perugia,
Abstract
AURICULAR TRANSCUTANEOUS HI-FREQUENCY E-MMUNOTHERAPY SEQUENCES (ATHENS) FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: 1-YEAR CHANGES IN SYNOVITIS, OSTEITIS, AND BONE EROSIONOrg: Spire Sciences, Inc, Boca Raton, United States, Clinical Research Centre, Boca Raton Regional Hospital, United States of America, Nesos Corp,